LightForce
The Science
Contact Us
Clinician’s login
(DE) LiteCure Medical
Lasertherapie
Benefits
Über LiteCure
The LiteCure Difference
Grundlagen
Dosierung
Terms
Klassen
Request Information
Für Ärzte
Warum Lasertherapie?
Partnerschaft mit uns
Clinical Testimonials
Watch Videos
Webinar Archive
Clinician’s Corner
Resources + Support
Request a Demo
For Patients
What to Expect
Safety + Efficacy
Patient Testimonials
Find a Practice with LiteCure
Watch Videos
Unsere Produkte
Neuer LightForce® EXP
Neuer LightForce® FX
LightForce® EX
LightForce® Pro
LCT-1000™
LightForce® Compass™
Empower™ DS
Education and Events
Newswire
Events
Laser Therapy Blog
Clinician’s Corner
Contact Us
Navigation
Lasertherapie
Benefits
Über LiteCure
The LiteCure Difference
Grundlagen
Dosierung
Terms
Klassen
Request Information
Für Ärzte
Warum Lasertherapie?
Partnerschaft mit uns
Clinical Testimonials
Watch Videos
Webinar Archive
Clinician’s Corner
Resources + Support
Request a Demo
For Patients
What to Expect
Safety + Efficacy
Patient Testimonials
Find a Practice with LiteCure
Watch Videos
Unsere Produkte
Neuer LightForce® EXP
Neuer LightForce® FX
LightForce® EX
LightForce® Pro
LCT-1000™
LightForce® Compass™
Empower™ DS
Education and Events
Newswire
Events
Laser Therapy Blog
Clinician’s Corner
Contact Us
Home
2014
February
04
APTA – Combined Sections Meeting (CSM) 2014
[ February 3, 2014 to February 6, 2014. ] Las Vegas, NV
Read more...
QUICKLINKS
LightForce FX
LightForce EXP
INFORMATION
DEMONSTRATION
CONTACT US
LOGIN
Related Items
PRODUCTS
VIDEOS
SUPPORT
NEWSWIRE
Event Calendar
« Dec
Feb »
January 2
Sun
Mon
Tue
Wed
Thu
Fri
Sat
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
EC
Featured News
02/15/17
[NEW Photobiomodulation Website Sheds Light on the Science of Laser Therapy]
03/02/17
[Live Webinar: 90 Day Laser Therapy Integration Strategies – An Approach to Clinical and Financial Success]
01/31/17
[Live Webinar: FAQs About Laser Therapy]
12/16/16
[Live Webinar: Real ROI on a Therapy Laser in Less Than 30 Days]
